Effects of 12 months of treatment with the PPARγ agonist rosiglitazone on brain glucose metabolism in Alzheimer's disease: A 18F-FDG PET study
Eugenii A. Rabiner, Sofia Tzimopoulou, Vincent J. Cunningham, Barbara Jeter, Marina Zvartau-Hind, Mary Castiglia, Praful Mistry, Nick P. Bird, Julian Matthews, Brandon Whitcher, Thomas E. Nichols, RobVolume:
5
Year:
2009
Language:
english
DOI:
10.1016/j.jalz.2009.05.642
File:
PDF, 62 KB
english, 2009